Forward Pharma A Price History

FWPDelisted Stock  USD 2.56  0.00  0.00%   
If you're considering investing in Forward Stock, it is important to understand the factors that can impact its price. As of today, the current price of Forward Pharma stands at 2.56, as last reported on the 24th of April, with the highest price reaching 2.56 and the lowest price hitting 2.56 during the day. We have found twenty-five technical indicators for Forward Pharma A, which you can use to evaluate the volatility of the firm. Please confirm Forward Pharma's Downside Deviation of 9.18, mean deviation of 3.81, and Coefficient Of Variation of 5208.24 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Forward Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FWP
Based on monthly moving average Forward Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Forward Pharma by adding Forward Pharma to a well-diversified portfolio.

Forward Pharma Stock Price History Chart

There are several ways to analyze Forward Stock price data. The simplest method is using a basic Forward candlestick price chart, which shows Forward Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Forward Stock Price History Data

The price series of Forward Pharma for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 3.19 with a coefficient of variation of 19.02. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.57. The median price for the last 90 days is 2.63. The company completed 1:7 stock split on 6th of December 2019. Forward Pharma A completed dividends distribution on 2017-09-12.
OpenHighLowCloseVolume
04/24/2024
 2.56  2.56  2.56  2.56 
02/28/2023 2.56  2.56  2.56  2.56  1.00 
02/27/2023 2.56  2.56  2.56  2.56  1.00 
02/24/2023 2.56  2.56  2.56  2.56  1,000.00 
02/23/2023 2.56  2.56  2.56  2.56  1.00 
02/22/2023 2.56  2.56  2.56  2.56  1.00 
02/21/2023 2.56  2.56  2.56  2.56  1,482 
02/17/2023 2.60  2.60  2.60  2.60  412.00 
02/16/2023 2.59  2.59  2.59  2.59  1.00 
02/15/2023 2.59  2.59  2.59  2.59  610.00 
02/14/2023 2.56  2.56  2.56  2.56  1.00 
02/13/2023 2.56  2.56  2.56  2.56  1.00 
02/10/2023 2.60  2.60  2.56  2.56  300.00 
02/09/2023 2.55  2.55  2.55  2.55  1.00 
02/08/2023 2.55  2.55  2.55  2.55  100.00 
02/07/2023 2.70  2.70  2.70  2.70  1.00 
02/06/2023 2.06  2.70  2.06  2.70  201.00 
02/03/2023 3.00  3.00  3.00  3.00  1.00 
02/02/2023 3.00  3.00  3.00  3.00  1.00 
02/01/2023 3.00  3.00  3.00  3.00  1.00 
01/31/2023 2.99  3.00  2.99  3.00  930.00 
01/30/2023 2.04  3.00  2.04  3.00  631.00 
01/27/2023 3.00  3.00  3.00  3.00  15,061 
01/26/2023 3.00  3.00  3.00  3.00  1,842 
01/25/2023 2.98  3.14  2.98  3.14  906.00 
01/24/2023 2.90  2.90  2.83  2.84  1,101 
01/23/2023 2.78  2.78  2.78  2.78  1,122 
01/20/2023 2.91  2.91  2.91  2.91  1.00 
01/19/2023 2.70  2.94  2.70  2.91  8,190 
01/18/2023 2.55  2.55  2.55  2.55  225.00 
01/17/2023 2.47  2.47  2.47  2.47  424.00 
01/16/2023 0.00  0.00  0.00  0.00  1.00 
01/13/2023 2.70  2.70  2.70  2.70  1.00 
01/12/2023 2.56  2.70  2.56  2.70  3,149 
01/11/2023 2.61  2.65  2.61  2.63  5,311 
01/10/2023 2.48  2.48  2.48  2.48  4,544 
01/09/2023 2.26  2.26  2.23  2.23  601.00 
01/06/2023 2.18  2.26  2.18  2.26  715.00 
01/05/2023 2.21  2.21  2.16  2.20  9,204 
01/04/2023 2.21  2.25  2.21  2.21  5,321 
01/03/2023 1.95  1.95  1.80  1.95  4,348 
12/30/2022 2.15  2.15  1.89  1.95  7,019 
12/29/2022 1.95  2.20  1.88  2.16  1,725 
12/28/2022 1.43  1.98  1.43  1.98  103,085 
12/27/2022 1.94  2.06  1.94  1.95  29,554 
12/23/2022 1.95  2.08  1.81  1.81  49,600 
12/22/2022 1.83  1.98  1.83  1.96  3,500 
12/21/2022 1.81  2.00  1.79  1.80  45,000 
12/20/2022 1.75  1.89  1.70  1.81  127,100 
12/19/2022 2.35  2.35  1.50  1.79  101,500 
12/16/2022 2.64  2.64  2.60  2.61  1,000.00 
12/15/2022 2.37  2.66  2.37  2.66  700.00 
12/14/2022 2.93  2.93  2.72  2.72  1,500 
12/13/2022 2.96  3.00  2.96  3.00  400.00 
12/12/2022 2.70  3.00  2.70  2.97  3,300 
12/09/2022 2.69  2.69  2.66  2.66  400.00 
12/08/2022 2.85  2.85  2.85  2.85  1,300 
12/07/2022 2.97  2.97  2.72  2.92  2,200 
12/06/2022 2.80  3.19  2.40  3.19  3,800 
12/05/2022 2.81  2.81  2.81  2.81  166.00 
12/02/2022 2.80  2.90  2.80  2.81  800.00 

About Forward Pharma Stock history

Forward Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Forward is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Forward Pharma A will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Forward Pharma stock prices may prove useful in developing a viable investing in Forward Pharma
Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Forward Pharma Stock Technical Analysis

Forward Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Forward Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Forward Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Forward Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Forward Pharma's price direction in advance. Along with the technical and fundamental analysis of Forward Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Forward to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Forward Stock

If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities